vk2735 viking therapeutics news

Viking Therapeutics Stock Swings Wildly

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results

Viking Therapeutics shares rose Monday morning before reversing course and declining after reporting the latest results from clinical trials of its weight loss drugs.

Benzinga.com · 1d

Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety

Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and improved prediabetic outcomes.

Hosted on MSN · 1d

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

The Motley Fool on MSN1d

Is Viking Therepautics a Buy Now?

Wall Street's been pounding the table on Viking Therapeutics because VK2735 could become the next and best dual ...

GlobalData on MSN18h

Viking stock fluctuates amid manufacturing concerns with obesity pill

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Wall Street Lunch: Viking Weight-Loss Pill Data Is Striking

Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 ...

Hosted on MSN1d

Viking Therapeutics stock jumps after weight-loss pill shows ‘great outcome’ in trial

Viking Therapeutics stock rose 5.5% in early trade Monday after the biotech posted data on its oral weight-loss drug showing better-than-expected results from a Phase 1 trial. The study of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results